Atria Wealth Solutions’s GSK GSK Stock Holding History

Atria Wealth Solutions’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$208K	Sell	5,375 -4,195	-44%	-$160K	﹤0.01%	1374
2025 Q1	$371K	Sell	9,570 -11,195	-54%	-$410K	﹤0.01%	1358
2024 Q4	$702K	Sell	20,765 -5,040	-20%	-$181K	0.01%	1074
2024 Q3	$1.06M	Sell	25,805 -8,133	-24%	-$333K	0.01%	893
2024 Q2	$1.31M	Buy	33,938 +3,310	+11%	+$139K	0.01%	782
2024 Q1	$1.32M	Sell	30,628 -1,390	-4%	-$57.3K	0.01%	791
2023 Q4	$1.19M	Buy	32,018 +3,736	+13%	+$134K	0.01%	796
2023 Q3	$1.03M	Sell	28,282 -2,044	-7%	-$72.5K	0.01%	798
2023 Q2	$1.08M	Sell	30,326 -284	-0.9%	-$10.2K	0.01%	803
2023 Q1	$1.1M	Buy	30,610 +8,905	+41%	+$312K	0.02%	760
2022 Q4	$766K	Sell	21,705 -9,076	-29%	-$302K	0.01%	883
2022 Q3	$910K	Buy	30,781 +6,887	+29%	+$261K	0.02%	746
2022 Q2	$1.3M	Sell	23,894 -5,824	-20%	-$322K	0.02%	584
2022 Q1	$1.64M	Buy	+29,718	New	+$1.61M	0.03%	547

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Atria Wealth Solutions's GSK Position: Q2 2025 in Review

Atria Wealth Solutions reduced its GSK (GSK) stake by 44% in Q2 2025, selling an estimated $160K and leaving 5,375 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Atria Wealth Solutions first reported a position in GSK in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.64M in Q1 2022. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Atria Wealth Solutions held 5,375 shares of GSK worth $208K as of Q2 2025.
Atria Wealth Solutions sold 4,195 GSK shares in Q2 2025, an estimated $160K.
GSK made up ﹤0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1374 holding.
Atria Wealth Solutions first reported a position in GSK in Q1 2022 and has held it in 14 quarters since.
Atria Wealth Solutions's GSK position peaked at $1.64M in Q1 2022.
891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.